A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the listing of patents in the Orange Book.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senior Senator for Washington. Democrat.
Last Updated: Jul 21, 2020
Length: 3 pages
Jul 21, 2020
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
S. 4253 (116th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 4253. This is the one from the 116th Congress.
This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2021). S. 4253 — 116th Congress: Second Look at Drug Patents Act of 2020. Retrieved from https://www.govtrack.us/congress/bills/116/s4253
“S. 4253 — 116th Congress: Second Look at Drug Patents Act of 2020.” www.GovTrack.us. 2020. June 22, 2021 <https://www.govtrack.us/congress/bills/116/s4253>
Second Look at Drug Patents Act of 2020, S. 4253, 116th Cong..
|title=S. 4253 (116th)
|accessdate=June 22, 2021
|author=116th Congress (2020)
|date=July 21, 2020
|quote=Second Look at Drug Patents Act of 2020
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.